Biochemical analysis reveals diverse bioactive compounds and therapeutic properties in Grewia asiatica fruit, suggesting broad potential for nutraceutical formulations.
Grewia asiatica L. (Phalsa) is a tropical Asian species widely cultivated for its edible fruit and diverse nutraceutical applications. The fruit pulp is nutritionally rich, containing water (80.8 g), protein (1.3 g), fat (0.9 g), carbohydrates (14.7 g), fiber (1.2 g), and essential minerals, alongside 18 amino acids—predominantly aspartic acid, glutamic acid, and leucine. It is also a significant source of vitamins A and C and various bioactive compounds such as anthocyanins, tannins, phenolics, and flavonoids. These constituents contribute to its broad pharmacological profile, including antioxidant, antidiabetic, antibacterial, antiviral, anticancer, anti-inflammatory, hepatoprotective, and immunomodulatory activities. Owing to these properties, Grewia asiatica has garnered increasing scientific interest, leading to its growing incorporation into pharmaceutical and nutraceutical formulations as a safe, cost-effective, and widely accessible natural resource.
No takes yet. Share an insight, caveat, or question.
Raj et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: